Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement.
Publication
, Journal Article
Aslam, S; Grossi, P; Schlendorf, KH; Holm, AM; Woolley, AE; Blumberg, E; Mehra, MR; working group members
Published in: J Heart Lung Transplant
May 2020
The advent of therapies for successful treatment of hepatitis C virus has allowed the heart and lung transplant community to re-explore the use of hepatitis C virus-positive donors for organ transplantation, with a benefit for many terminally ill patients. The consensus statements provided herein represent the current state of knowledge and expertise in this area, which we expect will continue to rapidly evolve over the next few years.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Heart Lung Transplant
DOI
EISSN
1557-3117
Publication Date
May 2020
Volume
39
Issue
5
Start / End Page
418 / 432
Location
United States
Related Subject Headings
- Tissue Donors
- Surgery
- Organ Transplantation
- Humans
- Hepatitis C
- Consensus
- Antiviral Agents
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Aslam, S., Grossi, P., Schlendorf, K. H., Holm, A. M., Woolley, A. E., Blumberg, E., … working group members. (2020). Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement. J Heart Lung Transplant, 39(5), 418–432. https://doi.org/10.1016/j.healun.2020.03.004
Aslam, Saima, Paolo Grossi, Kelly H. Schlendorf, Are M. Holm, Ann E. Woolley, Emily Blumberg, Mandeep R. Mehra, and working group members. “Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement.” J Heart Lung Transplant 39, no. 5 (May 2020): 418–32. https://doi.org/10.1016/j.healun.2020.03.004.
Aslam S, Grossi P, Schlendorf KH, Holm AM, Woolley AE, Blumberg E, et al. Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement. J Heart Lung Transplant. 2020 May;39(5):418–32.
Aslam, Saima, et al. “Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement.” J Heart Lung Transplant, vol. 39, no. 5, May 2020, pp. 418–32. Pubmed, doi:10.1016/j.healun.2020.03.004.
Aslam S, Grossi P, Schlendorf KH, Holm AM, Woolley AE, Blumberg E, Mehra MR, working group members. Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement. J Heart Lung Transplant. 2020 May;39(5):418–432.
Published In
J Heart Lung Transplant
DOI
EISSN
1557-3117
Publication Date
May 2020
Volume
39
Issue
5
Start / End Page
418 / 432
Location
United States
Related Subject Headings
- Tissue Donors
- Surgery
- Organ Transplantation
- Humans
- Hepatitis C
- Consensus
- Antiviral Agents
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology